NCT02327312
Terminated
Not Applicable
Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty
ConditionsPrimary Open-Angle Glaucoma
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Primary Open-Angle Glaucoma
- Sponsor
- Glaukos Corporation
- Enrollment
- 91
- Primary Endpoint
- IOP reduction
- Status
- Terminated
- Last Updated
- 3 years ago
Overview
Brief Summary
To evaluate the safety and effectiveness of Trabecular Micro-Bypass stents (two stents per study eye) vs. laser trabeculoplasty, in subjects with open angle glaucoma
Investigators
Eligibility Criteria
Inclusion Criteria
- •Open angle Glaucoma
Exclusion Criteria
- •Active corneal inflammation or edema
- •Choroidal detachment, effusion, choroiditis
Outcomes
Primary Outcomes
IOP reduction
Time Frame: up to 24 months
Secondary Outcomes
- % IOP reduction(up to 24 months)
Similar Trials
Completed
Not Applicable
A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients.Open-Angle GlaucomaNCT00326066Glaukos Corporation47
Completed
Phase 4
A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma SubjectsOpen-Angle GlaucomaNCT00326040Glaukos Corporation45
Completed
Phase 3
A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle GlaucomaOpen-Angle GlaucomaNCT00323284Glaukos Corporation240
Unknown
Phase 4
A Study of the Glaukos Trabecular Micro-bypass Stent in Open Angle Glaucoma Subjects 1 Stent Versus 2Open-Angle GlaucomaNCT00326079Glaukos Corporation61
Completed
Phase 4
A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.Open-Angle GlaucomaNCT00326014Glaukos Corporation58